 |
|
Noncoding RNAs as therapeutic targets in early stage diabetic kidney disease
Mitsuo Kato
Kidney Res Clin Pract. 2018;37(3):197-209. Published online 2018 Sep 30 DOI: https://doi.org/10.23876/j.krcp.2018.37.3.197
|
|
Citations to this article as recorded by
 Exploring the Therapeutic Significance of microRNAs and lncRNAs in Kidney Diseases
Luis Alberto Bravo-Vázquez, Sujay Paul, Miriam Guadalupe Colín-Jurado, Luis David Márquez-Gallardo, Luis Germán Castañón-Cortés, Antara Banerjee, Surajit Pathak, Asim K. Duttaroy
Genes.2024; 15(1): 123. CrossRef The role of non-protein-coding RNAs in ischemic acute kidney injury
Fatemeh Sabet Sarvestani, Afsoon Afshari, Negar Azarpira
Frontiers in Immunology.2024;[Epub] CrossRef Non-Coding RNAs in Kidney Stones
Guilin Wang, Jun Mi, Jiangtao Bai, Qiqi He, Xiaoran Li, Zhiping Wang
Biomolecules.2024; 14(2): 213. CrossRef Deciphering the role of MicroRNAs in diabetic nephropathy: Regulatory mechanisms and molecular insights
Nourhan M. Abdelmaksoud, Tohada M. AL-Noshokaty, Rehab Abdelhamid, Nourhan Abdellatif, Abdallah Mansour, Reem Mohamed, Asmaa Hamouda Mohamed, Nada Abd Elatif Khalil, Sara Sobhy Abdelhamid, Alaa Mohsen, Heba abdelaal, Ahmed Tawfik, Shereen Saeid Elshaer
Pathology - Research and Practice.2024; 256: 155237. CrossRef Long Non-Coding RNAs in Kidney Injury: A Comprehensive Review
Ramdas Bhat, Preeti Shanbhag
Journal of Prevention, Diagnosis and Management of Human Diseases.2024; (42): 39. CrossRef Elucidating ascorbate and aldarate metabolism pathway characteristics via integration of untargeted metabolomics and transcriptomics of the kidney of high-fat diet-fed obese mice
Hong Liang, Kang Song, Yasmina Abd‐Elhakim
PLOS ONE.2024; 19(4): e0300705. CrossRef LncRNA TUG1 ameliorates diabetic nephropathy via inhibition of PU.1/RTN1 signaling pathway
Dongdong Meng, Lina Wu, Zhifu Li, Xiaojun Ma, Shuiying Zhao, Di Zhao, Guijun Qin
Journal of Leukocyte Biology.2022; 111(3): 553. CrossRef Epigenetic modifications in diabetes
Renu A. Kowluru, Ghulam Mohammad
Metabolism.2022; 126: 154920. CrossRef Therapeutic application of extracellular vesicles for various kidney diseases: a brief review
Sul A Lee, Tae Hyun Yoo
BMB Reports.2022; 55(1): 3. CrossRef Role of resveratrol supplementation in regulation of glucose hemostasis, inflammation and oxidative stress in patients with diabetes mellitus type 2: A randomized, placebo-controlled trial
Wajiha Mahjabeen, Dilshad Ahmed Khan, Shakil Ahmed Mirza
Complementary Therapies in Medicine.2022; 66: 102819. CrossRef Pathophysiologic Mechanisms and Potential Biomarkers in Diabetic Kidney Disease
Chan-Young Jung, Tae-Hyun Yoo
Diabetes & Metabolism Journal.2022; 46(2): 181. CrossRef Long Non-Coding RNAs in the Pathogenesis of Diabetic Kidney Disease
Mengsi Hu, Qiqi Ma, Bing Liu, Qianhui Wang, Tingwei Zhang, Tongtong Huang, Zhimei Lv
Frontiers in Cell and Developmental Biology.2022;[Epub] CrossRef Novel biomarkers for diabetic kidney disease
Chan-Young Jung, Tae-Hyun Yoo
Kidney Research and Clinical Practice.2022; 41(Suppl 2): S46. CrossRef The role of lncRNAs in regulation of DKD and diabetes-related cancer
Yawei Cheng, Xiaowen Wu, Yujie Xia, Wenjun Liu, Peter Wang
Frontiers in Oncology.2022;[Epub] CrossRef Therapeutic effect of kidney tubular cells-derived conditioned medium on the expression of microRNA-377, Microrna-29a, aquapurin-1, biochemical, and histopathological parameters following diabetic nephropathy injury in rats
Esrafil Mansouri, Mahmoud Orazizadeh, SeyyedAli Mard, Armita Valizadeh Gorji, Mohammad Rashno, Fereshtesadat Fakhredini
Advanced Biomedical Research.2022; 11(1): 119. CrossRef Non-Coding RNAs as Biomarkers and Therapeutic Targets for Diabetic Kidney Disease
Yue-Yu Gu, Fu-Hua Lu, Xiao-Ru Huang, Lei Zhang, Wei Mao, Xue-Qing Yu, Xu-Sheng Liu, Hui-Yao Lan
Frontiers in Pharmacology.2021;[Epub] CrossRef Potential Repressive Impact of microRNA-20a on Renal Tubular Damage in Diabetic Kidney Disease by Targeting C-X-C Motif Chemokine Ligand 6
Shu-Zhong Wang, Ying-Li Zhang, Hong-Bo Shi
Archives of Medical Research.2021; 52(1): 58. CrossRef Peritoneal fibrosis and epigenetic modulation
Yi Wang, Yingfeng Shi, Min Tao, Shougang Zhuang, Na Liu
Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis.2021; 41(2): 168. CrossRef The expression profile of circANKRD36 and ANKRD36 as diagnostic biomarkers of chronic kidney disease in patients with type 2 diabetes mellitus
Nearmeen M. Rashad, Mohamed H. Sherif, Amal S. El-Shal, Mona A. E. Abdelsamad
Egyptian Journal of Medical Human Genetics.2021;[Epub] CrossRef Extracellular vesicles in kidneys and their clinical potential in renal diseases
Sul A Lee, Chulhee Choi, Tae-Hyun Yoo
Kidney Research and Clinical Practice.2021; 40(2): 194. CrossRef MicroRNAs in organ fibrosis: From molecular mechanisms to potential therapeutic targets
Hui Zhao, Ya-Long Feng, Tian Liu, Jing-Jing Wang, Jun Yu
Pathology - Research and Practice.2021; 225: 153588. CrossRef Development of Biomarkers and Molecular Therapy Based on Inflammatory Genes in Diabetic Nephropathy
Amit K. Maiti
International Journal of Molecular Sciences.2021; 22(18): 9985. CrossRef Circular RNAs; powerful microRNA sponges to overcome diabetic nephropathy
Alireza Mafi, Negar Yadegar, Marziyeh Salami, Raziyeh Salami, Omid Vakili, Esmat Aghadavod
Pathology - Research and Practice.2021; 227: 153618. CrossRef LncRNA KCNQ1OT1 affects cell proliferation, apoptosis and fibrosis through regulating miR-18b-5p/SORBS2 axis and NF-ĸB pathway in diabetic nephropathy
Ran Jie, Pengpeng Zhu, Jiao Zhong, Yan Zhang, Hongyan Wu
Diabetology & Metabolic Syndrome.2020;[Epub] CrossRef circRNAs Signature as Potential Diagnostic and Prognostic Biomarker for Diabetes Mellitus and Related Cardiovascular Complications
Mohamed Zaiou
Cells.2020; 9(3): 659. CrossRef Diagnostic, Prognostic, and Therapeutic Value of Non-Coding RNA Expression Profiles in Renal Transplantation
Adriana Franco-Acevedo, Zesergio Melo, Raquel Echavarria
Diagnostics.2020; 10(2): 60. CrossRef Identification of Cooperative Gene Regulation Among Transcription Factors, LncRNAs, and MicroRNAs in Diabetic Nephropathy Progression
Ling Chen, Binbin Wu, Shaobin Wang, Yu Xiong, Boya Zhou, Xianyi Cheng, Tao Zhou, Ruibang Luo, Tak-Wah Lam, Bin Yan, Junhui Chen
Frontiers in Genetics.2020;[Epub] CrossRef Extracellular vesicles in renal physiology and clinical applications for renal disease
Soon Hyo Kwon
The Korean Journal of Internal Medicine.2019; 34(3): 470. CrossRef Bariatric Surgery Alters microRNA Content of Circulating Exosomes in Patients with Obesity
Yun‐Ui Bae, Yongjin Kim, Haekyung Lee, Hyoungnae Kim, Jin Seok Jeon, Hyunjin Noh, Dong Cheol Han, Seongho Ryu, Soon Hyo Kwon
Obesity.2019; 27(2): 264. CrossRef The circulating exosomal microRNAs related to albuminuria in patients with diabetic nephropathy
Hyoungnae Kim, Yun-Ui Bae, Jin Seok Jeon, Hyunjin Noh, Hyeong Kyu Park, Dong Won Byun, Dong Cheol Han, Seongho Ryu, Soon Hyo Kwon
Journal of Translational Medicine.2019;[Epub] CrossRef Non-coding RNAs in kidney injury and repair
Zhiwen Liu, Ying Wang, Shaoqun Shu, Juan Cai, Chengyuan Tang, Zheng Dong
American Journal of Physiology-Cell Physiology.2019; 317(2): C177. CrossRef Adiponectin for the treatment of diabetic nephropathy
Jun Young Lee, Jae Won Yang, Byoung Geun Han, Seung Ok Choi, Jae Seok Kim
The Korean Journal of Internal Medicine.2019; 34(3): 480. CrossRef Genetic and Epigenetic Studies in Diabetic Kidney Disease
Harvest F. Gu
Frontiers in Genetics.2019;[Epub] CrossRef Molecular determinants of mesenchymal cell activation in fibroproliferative diseases
Loka R. Penke, Marc Peters-Golden
Cellular and Molecular Life Sciences.2019; 76(21): 4179. CrossRef
|